Waseem is an experienced market access and pricing consultant with global experience across the pharmaceutical and medical devices sector. Waseem has worked with products across all stages of the product lifecycle and relishes working collaboratively with his clients to achieve organisational objectives. With a multitude of experience across a wide array of therapeutic areas Waseem is able to support organisations with full or partial projects ranging from evidence generation, systematic reviews, landscape assessments, medical writing, MA strategy, HTA, Pricing Research and Dashboard development.

Recent project experience includes a list price decrease implementation across 33 countries in Europe, working in conjunction with the European Commission, Pricing analysis for an established brand identifying impacts from IRP, LOE, Biosimilars, Developing country profiles and proposals which were shared with member states and received acceptance in all 33 countries, medical writing and systematic literature reviews for a blockbuster oncology product which included writing GVD and AMCP dossiers in Endometrial Cancer, Cervical Cancer, Melanoma and TMB-H, Client Management and indirect management of a team of medical writers and a team of evidence generation members.

Waseem is a member of the European Medical Writers Association and currently undertaking a course at INSEAD on how to build digital partnerships and ecosystems. Waseem has worked with clients such as Bayer, Novartis, Merck, Sanofi, Qiagen, ResMed, iRhthym Technologies.

To learn more about Waseem please visit his Linkedin page or download his CV. References available upon request.